Primary |
Drug Use For Unknown Indication |
19.2% |
Convulsion |
12.3% |
Chronic Obstructive Pulmonary Disease |
11.0% |
Anxiety |
8.2% |
Coronary Artery Disease |
5.5% |
Alcohol Withdrawal Syndrome |
4.1% |
Depression |
4.1% |
Insomnia |
4.1% |
Osteoporosis |
4.1% |
Product Used For Unknown Indication |
4.1% |
Sedation |
4.1% |
Atrial Fibrillation |
2.7% |
Evidence Based Treatment |
2.7% |
Hypertension |
2.7% |
Panic Attack |
2.7% |
Prophylaxis |
2.7% |
Bipolar Disorder |
1.4% |
Blood Glucose Increased |
1.4% |
Drug Abuse |
1.4% |
Dyspnoea |
1.4% |
|
Drug Ineffective |
10.3% |
Headache |
10.3% |
Nausea |
10.3% |
Drug Screen False Positive |
6.9% |
Somnolence |
6.9% |
Tremor |
6.9% |
Amnesia |
3.4% |
Anterograde Amnesia |
3.4% |
Coma |
3.4% |
Completed Suicide |
3.4% |
Convulsion |
3.4% |
Death |
3.4% |
Drug Toxicity |
3.4% |
Dysgeusia |
3.4% |
Multiple Drug Overdose Intentional |
3.4% |
Neuroleptic Malignant Syndrome |
3.4% |
Pruritus |
3.4% |
Pulmonary Congestion |
3.4% |
Sopor |
3.4% |
Staphylococcal Infection |
3.4% |
|
Secondary |
Product Used For Unknown Indication |
24.1% |
Depression |
12.8% |
Chronic Obstructive Pulmonary Disease |
8.1% |
Restless Legs Syndrome |
6.8% |
Convulsion |
5.3% |
Drug Use For Unknown Indication |
4.9% |
Prophylaxis |
4.5% |
Hypertension |
4.0% |
Sedation |
3.6% |
Anxiety |
3.4% |
Osteoporosis |
3.4% |
Alcohol Withdrawal Syndrome |
3.2% |
Ill-defined Disorder |
2.6% |
Major Depression |
2.6% |
Atrial Fibrillation |
1.9% |
Cardiac Disorder |
1.9% |
Epilepsy |
1.9% |
Mucous Membrane Disorder |
1.9% |
Insomnia |
1.7% |
Agitation |
1.5% |
|
Suicide Attempt |
10.7% |
Fall |
9.5% |
Hepatitis Cholestatic |
9.5% |
Agitation |
7.1% |
Completed Suicide |
7.1% |
Disorientation |
7.1% |
Pruritus |
6.0% |
Somnolence |
6.0% |
Drug Ineffective |
4.8% |
Pregnancy |
4.8% |
Nausea |
3.6% |
Neuroleptic Malignant Syndrome |
3.6% |
Thyroid Disorder |
3.6% |
Disease Recurrence |
2.4% |
Dizziness |
2.4% |
Drug Abuse |
2.4% |
Drug Screen False Positive |
2.4% |
Frontotemporal Dementia |
2.4% |
Headache |
2.4% |
Hepatotoxicity |
2.4% |
|
Concomitant |
Drug Use For Unknown Indication |
23.6% |
Product Used For Unknown Indication |
20.6% |
Anxiety |
8.1% |
Depression |
7.1% |
Hypertension |
4.7% |
Epilepsy |
4.6% |
Pain |
4.3% |
Convulsion |
3.2% |
Cardiac Disorder |
2.9% |
Osteoporosis |
2.4% |
Insomnia |
2.2% |
Gastrooesophageal Reflux Disease |
2.1% |
Hypersensitivity |
2.1% |
Prophylaxis |
1.9% |
Rheumatoid Arthritis |
1.9% |
Infection Prophylaxis |
1.7% |
Acute Myeloid Leukaemia |
1.6% |
Hypothyroidism |
1.6% |
Bipolar Disorder |
1.6% |
Diabetes Mellitus |
1.6% |
|
Vomiting |
13.0% |
Suicide Attempt |
8.6% |
Tremor |
7.4% |
Somnolence |
6.2% |
Convulsion |
5.6% |
Weight Increased |
5.6% |
Sudden Death |
4.9% |
Off Label Use |
4.3% |
Suicidal Ideation |
4.3% |
Thrombocytopenia |
4.3% |
Urinary Tract Infection |
4.3% |
Wheezing |
4.3% |
Drug Ineffective |
3.7% |
Dyspnoea |
3.7% |
Transient Ischaemic Attack |
3.7% |
Weight Decreased |
3.7% |
Cerebrovascular Accident |
3.1% |
Death |
3.1% |
Gait Disturbance |
3.1% |
Headache |
3.1% |
|
Interacting |
Product Used For Unknown Indication |
75.4% |
Anaesthesia |
13.4% |
Restless Legs Syndrome |
8.9% |
Anaesthetic Premedication |
2.2% |
|
Drug Interaction |
31.6% |
Infectious Peritonitis |
21.1% |
Disorientation |
15.8% |
Fall |
15.8% |
Peritonitis |
15.8% |
|